Please login to the form below

Not currently logged in
Email:
Password:

turoctocog alfa

This page shows the latest turoctocog alfa news and features for those working in and with pharma, biotech and healthcare.

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten

In October, Novo secured US approval for NovoEight, a new long-acting Factor VIII for people with haemophilia A (turoctocog alfa), while it also has NN7999, a long-acting recombinant coagulation ... The company suffered a disappointment last year when it

Latest news

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    Novo Nordisk's haemophilia drug. Among the drugs backed by the CHMP, which provides guidance to the European Medicines Agency (EMA), was Novo Nordisk's NovoEight (turoctocog alfa) for use in

  • Novo Nordisk files new haemophilia drug in EU, US Novo Nordisk files new haemophilia drug in EU, US

    Novo Nordisk files new haemophilia drug in EU, US. Seeks approval for turoctocog alfa shortly after vatreptacog alfa pulled. ... Novo Nordisk has filed its first marketing applications for turoctocog alfa, a new recombinant factor VIII product for

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics